TRACON Pharms (TCON) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 127 251 sessions, December 1, 2023 to December 2, 2024
- Largest daily move
- +166.7% close of August 2, 2024
- 1-year change
- -99.2% closing prices, December 1, 2023 to December 2, 2024
- 1-month change
- -39.7% closing prices, November 1, 2024 to December 2, 2024
Company Description
TRACON Pharms (OTC: TCON) is classified in the biotechnology industry within the Healthcare sector.
TCON declined 99.2% in the 12 months to December 2, 2024. The last closing price was $0.0322.
This page collects what Stock Titan holds for TCON, including price data and latest news.
Stock Performance
TRACON Pharms (TCON) closed at $0.0322 on December 2, 2024. In the 12 months to December 2, 2024, the price lost 99.2%.
TCON Metrics & Rankings
Price returns through December 2, 2024. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
TRACON Pharms has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, earnings, conferences, stock split. View all TCON news →
SEC Filings
TCON Company Profile & Sector Positioning
TRACON Pharms (TCON) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing TCON often look at related companies in the same sector, including CSL Ltd (CMXHF), CSL Ltd (CSLLY), UCB SA NPV (UCBJF), UCB SA (UCBJY), and Genmab A/S DKK (GNMSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TCON's relative position within its industry.